Photonews Logo Photonews logo
  • Home
  • Pakistan
    • Punjab
    • Sindh
    • Khyber Pakhtunkhwa
    • Azad Jammu Kashmir
    • Balochistan
    • Gilgit – Baltistan
  • World
  • Business
  • Entertainment
  • Videos
    Gen V Season 2 trailer
    Videos

    Gen V Season 2 Trailer Cast, Plot, Premiere Details

    July 26, 2025 3 Min Read
    IShowSpeed Daniel La Belle race
    Videos

    IShowSpeed Beats Daniel La Belle in 40-Meter Race, Hits 41M Subscribers

    June 24, 2025 2 Min Read
    Cardi B new single Outside
    Videos

    Cardi B’s ‘Outside’ Single Sparks Buzz Over Offset and Stefon Diggs

    June 20, 2025 2 Min Read
  • Sports
  • Technology
  • Offbeat
  • Blog
  • Contact
Reading: Revolutionary Shift in Type 1 Diabetes Treatment with Semaglutide: Early Study Results
PhotoNews Pakistan PhotoNews Pakistan
Font ResizerAa
Search
  • Home
  • Pakistan
    • Punjab
    • Sindh
    • Khyber Pakhtunkhwa
    • Balochistan
    • Azad Jammu Kashmir
    • Gilgit – Baltistan
  • World
  • Business
  • Entertainment
  • Videos
  • Sports
  • Technology
  • Offbeat
  • Blog
  • Contact
Have an existing account? Sign In
Follow US
© 2022 Photonews. All Rights Reserved.
Semaglutide Type 1 Diabetes Treatment
PhotoNews Pakistan > Offbeat > Revolutionary Shift in Type 1 Diabetes Treatment with Semaglutide: Early Study Results
Offbeat

Revolutionary Shift in Type 1 Diabetes Treatment with Semaglutide: Early Study Results

Web Desk
By Web Desk Published September 9, 2023 3 Min Read
Share
SHARE

Medical researchers are astonished by the potential breakthrough in Type 1 diabetes treatment with the weight loss drug semaglutide, also known under Ozempic and Wegovy. The former is typically used for treating Type 2 diabetes, while the latter is favoured for weight loss. A recent study published in the New England Journal of Medicine divulged remarkable results where most participants, all Type 1 diabetes patients, quit using insulin shots with meals within three months. The study’s lead author, Dr. Paresh Dandona, expressed his disbelief at the rapid progress, likening the results to “science fiction”.

This development could signify a turning point in treating Type 1 diabetes, characterized by the body’s attack on beta cells responsible for insulin production. This is in contrast to Type 2 diabetes, where the body either doesn’t produce enough insulin or resists it, necessitating distinct treatment approaches. The promising results from the semaglutide use could potentially revolutionize the treatment plan for Type 1 diabetes patients, offering a solution to the challenging issue of controlling sugar levels.

Calls for Extensive Further Research

Despite the groundbreaking findings, experts emphasize the necessity for further and larger studies to validate these results. Dr. Dandona remains committed to advancing this potential shift in treatment strategy, with plans to initiate a more extensive study involving collaboration with diabetes investigators nationwide, pending necessary funding.

Other experts in the field share this enthusiasm and urge for substantial research to substantiate these claims. Dr. Michael Natter, an endocrinologist at NYU Langone Health, noted that while the findings are promising, making extensive claims based on a small, non-controlled study would be premature. Echoing this sentiment, Dr. Vanita Aroda, the director of diabetes clinical research at Brigham and Women’s Hospital in Boston, praised the focus on newly diagnosed patients and highlighted the urgent need to explore the potential benefits of such therapies for the larger population of individuals with Type 1 diabetes through comprehensive studies. This collective call for action reflects a cautious optimism in the medical community about the potential transformation in Type 1 diabetes treatment that semaglutide might bring about.

TAGGED:Featured
Share This Article
Facebook Twitter Pinterest Whatsapp Whatsapp LinkedIn Email Copy Link Print
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Advertisement

HBL Saving Made Easy
HBL Saving Made Easy

Recent Posts

Ellen DeGeneres and Portia de Rossi UK

Ellen DeGeneres Faces Lawsuit Over 2023 Car Accident in California

President Asif Ali Zardari in China’

Zardari’s China Visit Bolsters Pakistan’s Defense and Aviation Ties

Charlie Kirk After 2025 Shooting

Republicans Warn Against Disrespecting Charlie Kirk After Fatal Shooting

Post Archives

More Popular from Photonews

Canada’s Dunfee, Spain’s Perez at Tokyo 2025 Championships
Sports

Canada’s Dunfee, Spain’s Perez Win Gold at Tokyo 2025 Championships

3 Min Read
Pakistan Auto Sales Surge 28% in August 2025
Business

Pakistan’s Auto Sector Surges with 14,050 Car Sales in August 2025

2 Min Read
Sha'Carri Richardson
Sports

Sha’Carri Richardson Faces Controversy Ahead of 2025 World Title Defense

2 Min Read
Pakistan

Pakistan Plans New Tax for Jinnah Medical Complex with IMF Approval

Pakistan has asked the International Monetary Fund (IMF) to allow a new municipal tax through a…

September 12, 2025
Sports

Pakistan Cleared from WADA Watchlist After Months of Investigation

The World Anti-Doping Agency (WADA) has removed Pakistan from its watchlist after months of intense scrutiny.…

September 13, 2025
Top NewsWorld

UN General Assembly Backs Two-State Solution for Israel-Palestine Conflict

The United Nations General Assembly voted strongly in favour of a resolution supporting a two-state solution…

September 13, 2025
Tech

iPhone 17: Expected Features, Price, and Colors for Apple’s 2025 Release

Apple is set to unveil the iPhone 17 at its ‘Awe Dropping’ event on September 9,…

September 8, 2025
PhotoNews Pakistan

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

Categories

  • World
  • Pakistan
  • Punjab
  • Sindh
  • Khyber Pakhtunkhwa
  • Balochistan
  • Azad Jammu Kashmir

 

  • Top News
  • Business
  • Entertainment
  • Sports
  • Videos
  • Tech
  • Offbeat
  • Blog

© 2024 Phototnews
All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?